Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Rose

Showing results (201-210 of 227) with videos related to

Pageof 23
Sort By:
Molecular Oncology|November 11, 2025
Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107Jutta Schmitz, Anna L Bartkowiak, Michael Rose, et al.
Virchows Archiv : an International Journal of Pathology|March 22, 2020
Comparative genomic profiling of glandular bladder tumoursAngela Maurer, Nadina Ortiz-Bruechle, Karolina Guricova, et al.
Molecular Cancer|February 25, 2017
ITIH5 mediates epigenetic reprogramming of breast cancer cellsMichael Rose, Vera Kloten, Erik Noetzel, et al.
The Journal of Biological Chemistry|September 21, 2011
Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression?Glen Kristiansen, Junmin Hu, Daniela Wichmann, et al.
Oncogene|September 26, 2020
EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancerMichael Rose, Angela Maurer, Julia Wirtz, et al.
Oncogene|December 2, 2020
Correction: EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancerMichael Rose, Angela Maurer, Julia Wirtz, et al.
Molecular Oncology|February 20, 2024
ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migrationJennifer Kosinski, Antonio Sechi, Johanna Hain, et al.
Plastic and Reconstructive Surgery|September 12, 2018
Development of the BODY-Q Chest Module Evaluating Outcomes following Chest Contouring SurgeryAnne F Klassen, Manraj Kaur, Lotte Poulsen, et al.
Cancers|November 9, 2024
High Expression of the Tumor Suppressor Protein ITIH5 in Cholangiocarcinomas Correlates with a Favorable PrognosisVerena J Dreyer, Jia-Xin Shi, Michael Rose, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2022
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axisDuygu Ozmadenci, Jayanth S Shankara Narayanan, Jacob Andrew, et al.
Pageof 23

Showing results (201-210 of 227) with videos related to

Sort By:
Pageof 23
Molecular Oncology|November 11, 2025
Improving PARP inhibitor efficacy in bladder cancer without genetic BRCAness by combination with PLX51107Jutta Schmitz, Anna L Bartkowiak, Michael Rose, et al.
Virchows Archiv : an International Journal of Pathology|March 22, 2020
Comparative genomic profiling of glandular bladder tumoursAngela Maurer, Nadina Ortiz-Bruechle, Karolina Guricova, et al.
Molecular Cancer|February 25, 2017
ITIH5 mediates epigenetic reprogramming of breast cancer cellsMichael Rose, Vera Kloten, Erik Noetzel, et al.
The Journal of Biological Chemistry|September 21, 2011
Endogenous myoglobin in breast cancer is hypoxia-inducible by alternative transcription and functions to impair mitochondrial activity: a role in tumor suppression?Glen Kristiansen, Junmin Hu, Daniela Wichmann, et al.
Oncogene|September 26, 2020
EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancerMichael Rose, Angela Maurer, Julia Wirtz, et al.
Oncogene|December 2, 2020
Correction: EGFR activity addiction facilitates anti-ERBB based combination treatment of squamous bladder cancerMichael Rose, Angela Maurer, Julia Wirtz, et al.
Molecular Oncology|February 20, 2024
ITIH5 as a multifaceted player in pancreatic cancer suppression, impairing tyrosine kinase signaling, cell adhesion and migrationJennifer Kosinski, Antonio Sechi, Johanna Hain, et al.
Plastic and Reconstructive Surgery|September 12, 2018
Development of the BODY-Q Chest Module Evaluating Outcomes following Chest Contouring SurgeryAnne F Klassen, Manraj Kaur, Lotte Poulsen, et al.
Cancers|November 9, 2024
High Expression of the Tumor Suppressor Protein ITIH5 in Cholangiocarcinomas Correlates with a Favorable PrognosisVerena J Dreyer, Jia-Xin Shi, Michael Rose, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 25, 2022
Tumor FAK orchestrates immunosuppression in ovarian cancer via the CD155/TIGIT axisDuygu Ozmadenci, Jayanth S Shankara Narayanan, Jacob Andrew, et al.
Pageof 23